Linezolid 600 Mg per 300 ml IV Product Specifications
Anti-Bacterial
MRSA Infections
Liquid
Linezolid 600 Mg per 300 ml
Injection
Linezolid 600 Mg per 300 ml IV Trade Information
100000 Box Per Month
4 Week
Infusion
All India
WHO-GMP
Product Description
Details
Linezolid has a significantly higher rate of clinical success as compared with vancomycin in the treatment of methicillin resistant Staphylococcus aureus pneumonia. Pharmacotherapy
Linezolid has better outcome than daptomycin in mortality rates among patients treated for VRE (vancomycin-resistant Enterococcus bacteraemia) bacteraemia
Linezolid shows an immunomodulatory effect, such as inhibition of inflammatory cytokine production